Abstract
Methods to detect immunolabeled molecules at increasingly higher resolutions, even when present at low levels, are revolutionizing immunohistochemistry (IHC). These technologies can be valuable for the management and examination of rare patient tissue specimens, and for improved accuracy of early disease detection. The purpose of this article is to highlight recent multiplexing methods that are candidates for more prevalent use in clinical research and potential translation to the clinic. Multiplex IHC methods, which permit identification of at least 3 and up to 30 discrete antigens, have been divided into whole-section staining and spatially-patterned staining categories. Associated signal enhancement technologies that can enhance performance and throughput of multiplex IHC assays are also discussed. Each multiplex IHC technique, detailed herein, is associated with several advantages as well as tradeoffs that must be taken into consideration for proper evaluation and use of the methods.
Financial & competing interests disclosure
S Takayama and J White own stock in PHASIQ, Inc., a company that is commercializing technology related to ATPS. S Takayama is supported by grants from the National Institutes of Health (CA170198) and the Coulter Foundation Grant to the University of Michigan. A R Dixon is supported by the National Institutes of Health sponsored, University of Michigan Hearing, Balance, and Chemical Senses Program (T32 DC00011). A R Dixon is supported by the University of Michigan Hearing, Balance, and Chemical Senses Program, sponsored by the National Institutes of Health (T32 DC00011). C Bathany is supported by the Basic Science Research Program (2013R1A1A2064729) of the National Research Foundation of Korea through the Ministry of Education, Science and Technology. K F Barald is supported by a grant from the National Science Foundation (IOS1146132). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Key issuesNo single biomarker or protein can specifically and sensitively reveal all relevant histological correlates to pathological states.
Multiplex immunohistochemistry allows visualization of more than one antigen at a time, but can suffer from antibody cross-talk, signal overlap and procedural complexities.
Multiplex immunohistochemistry can reduce inter-experiment error compared to performing several singleplex assays.
Use of multiplexing methods is critical when available tissue samples are minimal in number or in tissue area.
Increasing levels of multiplexing demand higher skills and experience from users or development of new automated approaches.
With colorimetric and fluorescent multiplexing techniques, methods to minimize autofluorescence and deconvolute spectral overlap become critical.
With spatially-patterned multiplexing techniques, it is difficult to know whether different antigens are co-localized or not, and there is a larger chance that rare markers may be missed.
User-friendly and cost-effective multiplexing systems that improve upon signal sensitivity and specificity while reducing batch-to-batch and user-to-user variability are needed.
Notes
Sauter G, Simon R, Hillan K. Tissue microarrays in drug discovery. Nat Rev Drug Discov 2003;2(12):962-72 Murphy RF. Putting proteins on the map. Nat Biotech 2006;24(10):1223-4 Gannot G, Tangrea MA, Richardson AM, et al. Layered expression scanning: Multiplex molecular analysis of diverse life science platforms. Clin Chim Acta 2007;376(1–2):9-16 Giesen C, Wang HAO, Schapiro D, et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Meth 2014;11(4):417-22 Sauter G, Simon R, Hillan K. Tissue microarrays in drug discovery. Nat Rev Drug Discov 2003;2(12):962-72 Kim M, Kwon S, Kim T, et al. Quantitative proteomic profiling of breast cancers using a multiplexed microfluidic platform for immunohistochemistry and immunocytochemistry. Biomaterials 2011;32(5):1396-403 Furuya T, Ikemoto K, Kawauchi S, et al. A novel technology allowing immunohistochemical staining of a tissue section with 50 different antibodies in a single experiment. J Histochem Cytochem 2004;52(2):205-10 Lovchik RD, Kaigala GV, Georgiadis M, Delamarche E. Micro-immunohistochemistry using a microfluidic probe. Lab Chip 2012;12(6):1040-3 Frampton JP, Tsuei M, White JB, et al. Aqueous two-phase system-mediated antibody micropatterning enables multiplexed immunostaining of cell monolayers and tissues. Biotechnol J 2015;10(1):121-5 Wu X, Liu H, Liu J, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotech 2003;21(1):41-6 Oliver C. Use of immunogold with silver enhancement. In: Javois L, editor. Immunocytochemical Methods and Protocols. Humana Press, Totowa, NJ; 1999. p. 241-5 Wang G, Achim CL, Hamilton RL, et al. Tyramide signal amplification method in multiple-label immunofluorescence confocal microscopy. Methods (San Diego, Calif.) 1999;18(4):459-64 Gusev Y, Sparkowski J, Raghunathan A, et al. Rolling circle amplification : a new approach to increase sensitivity for immunohistochemistry and flow cytometry. Am J Pathol 2001;159(1):63-9 Vosse BAH, Seelentag W, Bachmann A, et al. Background staining of visualization systems in immunohistochemistry: Comparison of the avidin-biotin complex system and the envision + system. Appl Immunohistochem Mol Morphol 2007;15(1):103-7 Becker JS, Zoriy M, Matusch A, et al. Bioimaging of metals by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). Mass Spectrom Rev 2010;29(1):156-75 Glass G, Papin J, Mandell J. Simple: A Sequential Immunoperoxidase labeling and erasing method. J Histochem Cytochem 2009;57(10):899-905 Schubert W, Bonnekoh B, Pommer A, et al. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat Biotechnol 2006;24(10):1270-8 Sauter G, Simon R, Hillan K. Tissue microarrays in drug discovery. Nat Rev Drug Discov 2003;2(12):962-72 Kim M, Kim T, Kong S-Y, et al. Breast cancer diagnosis using a microfluidic multiplexed immunohistochemistry platform. PLoS One 2010;5(5):e10441 Kim M, Kwon S, Kim T, et al. Quantitative proteomic profiling of breast cancers using a multiplexed microfluidic platform for immunohistochemistry and immunocytochemistry. Biomaterials 2011;32(5):1396-403 Frampton JP, Tsuei M, White JB, et al. Aqueous two-phase system-mediated antibody micropatterning enables multiplexed immunostaining of cell monolayers and tissues. Biotechnol J 2015;10(1):121-5